Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Messenger RNA (mRNA) vaccines are being used for COVID-19, but still suffer from the critical issue of mRNA instability and degradation, which is a major obstacle in the storage, distribution, and efficacy of the vaccine. Previous work showed that optimizing secondary structure stability lengthens mRNA half-life, which, together with optimal codons, increases protein expression. Therefore, a principled mRNA design algorithm must optimize both structural stability and codon usage to improve mRNA efficiency. However, due to synonymous codons, the mRNA design space is prohibitively large, e.g., there are $\sim\!10^{632}$ mRNAs for the SARS-CoV-2 Spike protein, which poses insurmountable challenges to previous methods. Here we provide a surprisingly simple solution to this hard problem by reducing it to a classical problem in computational linguistics, where finding the optimal mRNA is akin to finding the most likely sentence among similar sounding alternatives. Our algorithm, named LinearDesign, takes only 11 minutes for the Spike protein, and can jointly optimize stability and codon usage. Experimentally, without chemical modification, our designs substantially improve mRNA half-life and protein expression in vitro, and dramatically increase antibody response by up to 23$\times$ in vivo, compared to the codon-optimized benchmark. Our work enables the exploration of highly stable and efficient designs that are previously unreachable and is a timely tool not only for vaccines but also for mRNA medicine encoding all therapeutic proteins (e.g., monoclonal antibodies and anti-cancer drugs).
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
Où se fait cette recherche
-
Oregon State University pays non établi dans la noticeUniversité ou école supérieure
-
University of Rochester Medicine pays non établi dans la noticeÉtablissement de santé
-
Baidu Research USA pays non établi dans la noticeInstitution
-
School of EECS pays non établi dans la noticeUniversité ou école supérieure
-
CUC GUG CUC ACC UGA codons AUG UUC GUC UUC CUU GUC CUU . . pays non établi dans la noticeInstitution
-
CUG UAC ACC UGA UUU GUC UUU CUC GUC CUC . . pays non établi dans la noticeInstitution
-
UAC ACA UAA UUU GUU UUU UUG GUU UUG UAU ACU UAG GUA UUA GUA UUA ACG CUA CUA pays non établi dans la noticeInstitution
-
UAU ACA UAA GUU CUU GUU CUU . . . ACU UAG GUA UUG GUA UUG ACG UUA UUA CUA CUA pays non établi dans la noticeInstitution
-
Stemirna Therapeutics Inc. pays non établi dans la noticeEntreprise
-
Center for RNA Biology pays non établi dans la noticeInstitution
-
Dept. of Biochemistry & Biophysics pays non établi dans la noticeInstitution
-
University of Rochester Medical Center Dept. of Biostatistics & Computational Biology pays non établi dans la noticeUniversité ou école supérieure
Oregon State University, University of Rochester Medicine et Baidu Research USA, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.